Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Zappasodi

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Leukemia|April 6, 2007
A different schedule of zoledronic acid can reduce the risk of the osteonecrosis of the jaw in patients with multiple myelomaA Corso, M Varettoni, P Zappasodi, et al.
Annals of Hematology|July 3, 2003
Urinary proteins in multiple myeloma: correlation with clinical parameters and diagnostic implicationsA Corso, P Zappasodi, C Pascutto, et al.
Haematologica|October 30, 1998
Management of acute promyelocytic leukemia relapse in the ATRA eraC Castagnola, M Lunghi, A Corso, et al.
Annals of Hematology|November 11, 2020
Venetoclax and azacytidine combination is an effective bridge to transplant strategy in relapsed/refractory acute myeloid leukemia patientsP Zappasodi, M Brociner, G Merati, et al.
Annals of Hematology|July 6, 2004
Modification of thrombomodulin plasma levels in refractory myeloma patients during treatment with thalidomide and dexamethasoneA Corso, A Lorenzi, V Terulla, et al.
Annals of Hematology|August 25, 1999
Assessment of renal function in patients with multiple myeloma: the role of urinary proteinsA Corso, G Serricchio, P Zappasodi, et al.
Leukemia Research|December 22, 2007
Low efficacy of thalidomide in improving response after induction in multiple myeloma patients who are candidates for high-dose therapyA Corso, S Mangiacavalli, L Barbarano, et al.
Bone Marrow Transplantation|September 1, 2000
Blood stem cell collections in multiple myeloma: definition of a scoring systemA Corso, S Caberlon, G Pagnucco, et al.
Leukemia|July 9, 2004
Osteoprotegerin serum levels in multiple myeloma and MGUS patients compared with age- and sex-matched healthy controlsA Corso, A Dovio, C Rusconi, et al.
Bone Marrow Transplantation|September 27, 2005
Efficacy, toxicity and feasibility of a shorter schedule of DCEP regimen for stem cell mobilization in multiple myelomaA Corso, S Mangiacavalli, A Nosari, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Leukemia|April 6, 2007
A different schedule of zoledronic acid can reduce the risk of the osteonecrosis of the jaw in patients with multiple myelomaA Corso, M Varettoni, P Zappasodi, et al.
Annals of Hematology|July 3, 2003
Urinary proteins in multiple myeloma: correlation with clinical parameters and diagnostic implicationsA Corso, P Zappasodi, C Pascutto, et al.
Haematologica|October 30, 1998
Management of acute promyelocytic leukemia relapse in the ATRA eraC Castagnola, M Lunghi, A Corso, et al.
Annals of Hematology|November 11, 2020
Venetoclax and azacytidine combination is an effective bridge to transplant strategy in relapsed/refractory acute myeloid leukemia patientsP Zappasodi, M Brociner, G Merati, et al.
Annals of Hematology|July 6, 2004
Modification of thrombomodulin plasma levels in refractory myeloma patients during treatment with thalidomide and dexamethasoneA Corso, A Lorenzi, V Terulla, et al.
Annals of Hematology|August 25, 1999
Assessment of renal function in patients with multiple myeloma: the role of urinary proteinsA Corso, G Serricchio, P Zappasodi, et al.
Leukemia Research|December 22, 2007
Low efficacy of thalidomide in improving response after induction in multiple myeloma patients who are candidates for high-dose therapyA Corso, S Mangiacavalli, L Barbarano, et al.
Bone Marrow Transplantation|September 1, 2000
Blood stem cell collections in multiple myeloma: definition of a scoring systemA Corso, S Caberlon, G Pagnucco, et al.
Leukemia|July 9, 2004
Osteoprotegerin serum levels in multiple myeloma and MGUS patients compared with age- and sex-matched healthy controlsA Corso, A Dovio, C Rusconi, et al.
Bone Marrow Transplantation|September 27, 2005
Efficacy, toxicity and feasibility of a shorter schedule of DCEP regimen for stem cell mobilization in multiple myelomaA Corso, S Mangiacavalli, A Nosari, et al.
Pageof 3